Both type I and III collagens, which are core components of lung interstitial ECM and predominant in chronic fibrotic diseases25, were increased in lung lesions of TB, LUAD, and sarcoidosis patients, consistent with clinical observation that these diseases are generally associated with fibrotic progression and thus impaired lung architecture and function2,25,45. This evidence concerns the gene SGCG and tuberculosis.